Rukobia Approved for Patients With Multidrug-Resistant HIV

TUESDAY, July 7, 2020 -- A new type of antiretroviral medication, Rukobia (fostemsavir), has been approved for people with HIV who have not had success with other therapies, the U.S. Food and Drug Administration announced Thursday. Rukobia, 600 mg...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news